Chemotherapy and quality of life in advanced NSCLC

British Journal of Cancer (2001) 85, 137–137. doi:10.1054/bjoc.2001.1851 www.bjcancer.com
Published online 3 July 2001

D Farrugia¹ and R Lewis¹

¹Consultant Medical Oncologist, Cheltenham General Hospital, Sandford Road, Cheltenham, GL53 7AN, UK
²Consultant Respiratory Physician, Castle Street Branch, Worcester Royal Infirmary, Worcester, WR1 3AS

Anderson H (2000) Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome. Br J Cancer 83: 447–453, 10.1054/bjoc.2000.1307 | Article | PubMed | ISI | ChemPort |
De Deyn P and D'Hooge R (1996) Placebos in clinical practice and research. J Med Ethics 22: 140–146 | PubMed |
Slevin M (1990) Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses and general public. Br Med J 300: 1458–1460 | ISI | ChemPort |

ABSTRACT NAVIGATION - ABSTRACT

Postdoctoral Position
- Fox Chase Cancer Center
- Philadelphia, Pennsylvania, United States, 19111
Faculty Positions in Immunology
- Harvard Medical School (HMS), Dana-Farber Cancer Institute (DFCI)
- Boston, MA